论文部分内容阅读
IMB-86001是我所与山东新华制药厂共同开发的新型的依诺沙星衍生物,具有广谱强效抗菌活性,实验结果表明,体外抗菌活性与环丙沙星相似,明显强于依诺沙星(ENX)
IMB-86001 is a novel enoxacin derivative developed by our company with Shandong Xinhua Pharmaceutical Factory. It has a broad spectrum of potent antibacterial activity. The experimental results show that the antibacterial activity in vitro is similar to that of ciprofloxacin, which is obviously stronger than that of Enox Shaoxing (ENX)